Search research articles
Contact Us
Filters
Showing results (291-300 of 315) with videos related to
Page
of 32
Sort By:
BMJ Open
|
April 3, 2023
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury
Peter Pickkers, Derek C Angus, Jacques Arend, et al.
Intensive Care Medicine
|
March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)
Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Intensive Care Medicine
|
January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)
Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Clinical and Experimental Nephrology
|
November 12, 2019
Guideline on the use of iodinated contrast media in patients with kidney disease 2018
Yoshitaka Isaka, Hiromitsu Hayashi, Kazutaka Aonuma, et al.
Japanese Journal of Radiology
|
November 12, 2019
Guideline on the use of iodinated contrast media in patients with kidney disease 2018
Yoshitaka Isaka, Hiromitsu Hayashi, Kazutaka Aonuma, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
November 12, 2019
Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018
Yoshitaka Isaka, Hiromitsu Hayashi, Kazutaka Aonuma, et al.
Clinical and Experimental Nephrology
|
October 25, 2023
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Clinical and Experimental Nephrology
|
December 9, 2023
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Contributions to Nephrology
|
May 22, 2013
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI)
Peter A McCullough, Josee Bouchard, Sushrut S Waikar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 18, 2020
Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis
Christian Albert, Antonia Zapf, Michael Haase, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 315) with videos related to
Sort By:
Page
of 32
BMJ Open
|
April 3, 2023
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury
Peter Pickkers, Derek C Angus, Jacques Arend, et al.
Intensive Care Medicine
|
March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)
Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Intensive Care Medicine
|
January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)
Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Clinical and Experimental Nephrology
|
November 12, 2019
Guideline on the use of iodinated contrast media in patients with kidney disease 2018
Yoshitaka Isaka, Hiromitsu Hayashi, Kazutaka Aonuma, et al.
Japanese Journal of Radiology
|
November 12, 2019
Guideline on the use of iodinated contrast media in patients with kidney disease 2018
Yoshitaka Isaka, Hiromitsu Hayashi, Kazutaka Aonuma, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
November 12, 2019
Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018
Yoshitaka Isaka, Hiromitsu Hayashi, Kazutaka Aonuma, et al.
Clinical and Experimental Nephrology
|
October 25, 2023
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Clinical and Experimental Nephrology
|
December 9, 2023
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, et al.
Contributions to Nephrology
|
May 22, 2013
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI)
Peter A McCullough, Josee Bouchard, Sushrut S Waikar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 18, 2020
Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis
Christian Albert, Antonia Zapf, Michael Haase, et al.
Page
of 32